DAHON TECH (02543) plans to implement full circulation of H shares.

22:26 26/08/2026

Daheng Science and Technology (02543) announced that the board of directors has reviewed and approved the proposal for full circulation of H shares on August 26, 2026. This will involve converting the 13.2318 million unlisted shares held by six domestic shareholders of the company into H shares (accounting for approximately 40.35% of the total shares issued as of the date of this announcement). After obtaining all relevant approvals (including filing with the China Securities Regulatory Commission) and complying with all applicable rules and regulations, these unlisted shares will be converted into H shares, and the company will also apply to the Hong Kong Stock Exchange for the listing and trading of these H shares (conversion and listing). The conversion and listing must be approved by shareholders at the second extraordinary general meeting of 2026 to be held on September 15, 2026, by ordinary resolution in order to take effect.

DAHON TECH (02543) announced that the board of directors approved the implementation of the proposal for full circulation of H shares on August 26, 2026. This will involve the conversion of 13,231,800 unlisted shares held by six domestic shareholders into H shares of the company, representing approximately 40.35% of the total issued shares as of the date of this announcement. After obtaining all necessary approvals (including registration with the China Securities Regulatory Commission) and complying with all applicable rules and regulations, these unlisted shares will be converted into H shares, and the company will apply to the Stock Exchange for the listing and trading of these H shares (conversion and listing). The conversion and listing are subject to the approval of shareholders at the second extraordinary general meeting of 2026, to be held on September 15, 2026, via an ordinary resolution.

US Stock Market Move | The MSCI index exclusion risk strikes again, and Strategy (MSTR.US) has dropped over 4%.

MP CARDIOFLOW-B(02160) has appointed Zhang Ruinian as the company's president.

KAFELAKU COFFEE (01869) released its interim results, reporting a loss attributable to shareholders of HKD 10.219 million, a year-on-year decrease of 12.09%.

US Stock Market Move | The MSCI index exclusion risk strikes again, and Strategy (MSTR.US) has dropped over 4%.

MP CARDIOFLOW-B(02160) has appointed Zhang Ruinian as the company's president.

KAFELAKU COFFEE (01869) released its interim results, reporting a loss attributable to shareholders of HKD 10.219 million, a year-on-year decrease of 12.09%.